United Community Banks Inc Ordinary Shares UCB 深 沪
已收盘 12-19 16:00:00 美东时间
32.26
-0.100
-0.31%
华盛通- 最 高32.51
- 今 开32.25
- 成交量 141.71万股
- 最 低 31.95
- 昨 收 32.36
- 总市值 39.36亿
- 52周最高 33.59
- 市盈率 静 15.81
- 换手率 1.16%
- 52周最低 22.19
- 委 比 63.44%
- 总股本 1.22亿
- 历史最高 34.16
- 量 比 1.62
- 振 幅 1.73%
- 历史最低 22.19
- 每 手 1
- 风险率 2.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Biogen To Present Data From Trials Evaluating Dapirolizumab Pegol At American College Of Rheumatology Convergence 2025 In Chicago
Biogen Inc. (Nasdaq: BIIB) today announced upcoming presentations from studies evaluating dapirolizumab pegol (DZP), a novel Fc-free anti-CD40L drug candidate, in systemic lupus erythematosus (SLE) to be presented
10-22 19:37
United Community Banks Q3 Adj. EPS $0.75 Beats $0.70 Estimate, Sales $276.848M Beat $271.105M Estimate
United Community Banks (NYSE:UCB) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.70 by 7.76 percent. This is a 31.58 percent increase over earnings of $0.57 per share from
10-22 19:30
Earnings Scheduled For October 22, 2025
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is estimated to repor...
10-22 16:32
An Overview of United Community Banks's Earnings
United Community Banks (NYSE:UCB) is preparing to release its quarterly earning...
10-22 02:01
矿业巨头交出靓丽三季度财报：净利润同比大增逾五成！ | 盘后公告精选
矿业巨头三季度净利超170亿元，同比大增逾五成！消费电子龙头终止近百亿港元收购；国产GPU龙头与某GIS平台企业共同打造全国产化软硬件一体解决方案……
10-17 21:08
Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2
Adicet Bio reported strong Phase 1 lupus trial results with ADI-001, showing 100% response in nephritis patients and raising $80 million to fund Phase 2.
10-07 23:05
AI「学不会」竟成相变探针！UCSD华人联手谷歌等，曝光量子纠缠秘密
来源：新智元 来自加州大学圣地亚哥分校（UCSD）的华人学者Wanda Hou，与加州大学伯克利分校以及Google QuantumAI合作，在...
10-05 12:19
美股异动 | 医药股延续涨势！阿斯利康涨近7%，葛兰素史克涨超4%
医药股延续涨势！阿斯利康涨近7%，葛兰素史克涨超4%；金价持续冲高！泛美白银、哈莫尼黄金涨约3%；美国锂业公司LAC涨超18%>>
10-01 21:53
MoonLake rebounds despite downgrades prompted by trial setback
MoonLake Immunotherapeutics (NASDAQ:MLTX) traded higher on Tuesday even as Wall Street opted to downgrade the Swiss biotech following a late-stage trial setback for its lead candidate, sonelokimab, wh...
10-01 01:34
美股异动 | CoreWeave盘中一度大涨超15%！与Meta签署142亿美元算力供应协议
CoreWeave盘中一度大涨超15%！与Meta签署142亿美元算力供应协议；部分半导体概念股走强，美光科技、迈威尔科技涨超2%，英伟达涨超1%>>
09-30 22:07
